Microbiota y Salud Integral: Del Equilibrio a la Enfermedad
Resumen
La microbiota humana constituye uno de los sistemas biológicos más complejos e influyentes en la salud del hospedero. Su composición filogenética varía según el sitio anatómico y se regula mediante factores intrínsecos y extrínsecos a lo largo de toda la vida. El equilibrio entre eubiosis y disbiosis determina en gran medida la integridad inmunológica, metabólica y neurológica del individuo. Esta revisión integra la evidencia científica más actualizada sobre la composición, desarrollo y modulación de la microbiota humana, así como sus interacciones con el sistema inmunológico, la inflamación crónica y el eje microbiota-intestino-cerebro. Se discuten mecanismos moleculares subyacentes a enfermedades metabólicas, autoinmunes, neurodegenerativas y psiquiátricas, y se analizan intervenciones terapéuticas emergentes como los psicobióticos. La comprensión integral de este ecosistema microbiano es fundamental para el desarrollo de estrategias diagnósticas y terapéuticas de nueva generación.
Descargas
Citas
Afzaal, M., Saeed, F., Shah, Y. A., Hussain, M., Rabail, R., Socol, C. T., Hassoun, A., Pateiro, M., Lorenzo, J. M., Rusu, A. V., & Aadil, R. M. (2022). Human gut microbiota in health and disease: Unveiling the relationship. Frontiers in Microbiology, 13, 999001. https://doi.org/10.3389/fmicb.2022.999001
Alali, M. A., & Shori, A. B. (2026). Understanding the human gut microbiome: from composition to disease association. Frontiers in Microbiomes, 5(1717288), 1717288. https://doi.org/10.3389/frmbi.2026.1717288
Asad, A., Kirk, M., Zhu, S., Dong, X., & Gao, M. (2025). Effects of prebiotics and probiotics on symptoms of depression and anxiety in clinically diagnosed samples: Systematic review and meta-analysis of randomized controlled trials. Nutrition Reviews, 83(7), e1504–e1520. https://doi.org/10.1093/nutrit/nuae177
Baindara, P., & Mandal, S. M. (2024). Editorial: The interplay of gut-microbiome between infection and inflammation. Frontiers in Cellular and Infection Microbiology, 14, 1413473. https://doi.org/10.3389/fcimb.2024.1413473
Barron, M. (2025, July 30). Aging and the Gut: The Microbiome’s Second Act. ASM.org. https://asm.org/articles/2025/july/aging-gut-the-microbiome-second-act
Bautista, J., & López-Cortés, A. (2025). Microbial beginnings: determinants and disruptions of the neonatal microbiome. Frontiers in Microbiology, 16(1672780), 1672780. https://doi.org/10.3389/fmicb.2025.1672780
Bergentall, M., Tremaroli, V., Sun, C., Henricsson, M., Khan, M. T., Mannerås Holm, L., Olsson, L., Bergh, P.-O., Molinaro, A., Mardinoglu, A., Caesar, R., Nieuwdorp, M., & Bäckhed, F. (2025). Gut microbiota mediates SREBP-1c-driven hepatic lipogenesis and steatosis in response to zero-fat high-sucrose diet. Molecular Metabolism, 97(102162), 102162. https://doi.org/10.1016/j.molmet.2025.102162
Bertollo, A. G., Santos, C. F., Bagatini, M. D., & Ignácio, Z. M. (2025). Hypothalamus-pituitary-adrenal and gut-brain axes in biological interaction pathway of the depression. Frontiers in Neuroscience, 19, 1541075. https://doi.org/10.3389/fnins.2025.1541075
Boursier, J., Mueller, O., Barret, M., Machado, M., Fizanne, L., Araujo-Perez, F., Guy, C. D., Seed, P. C., Rawls, J. F., David, L. A., Hunault, G., Oberti, F., Calès, P., & Diehl, A. M. (2016). The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota. Hepatology (Baltimore, Md.), 63(3), 764–775. https://doi.org/10.1002/hep.28356
Braga, J. D., Thongngam, M., & Kumrungsee, T. (2024). Gamma-aminobutyric acid as a potential postbiotic mediator in the gut-brain axis. Npj Science of Food, 8(1), 16. https://doi.org/10.1038/s41538-024-00253-2
Byrd, A. L., Belkaid, Y., & Segre, J. A. (2018). The human skin microbiome. Nature Reviews. Microbiology, 16(3), 143–155. https://doi.org/10.1038/nrmicro.2017.157
Chen, L., Zhang, L., Hua, H., Liu, L., Mao, Y., & Wang, R. (2024). Interactions between toll-like receptors signaling pathway and gut microbiota in host homeostasis. Immunity, Inflammation and Disease, 12(7), e1356. https://doi.org/10.1002/iid3.1356
Chen, Y., Zhang, H., Cameron, M., & Sejnowski, T. (2024). Predictive sequence learning in the hippocampal formation. Neuron, 112(15), 2645–2658.e4. https://doi.org/10.1016/j.neuron.2024.05.024
Coscia, A., Bardanzellu, F., Caboni, E., Fanos, V., & Peroni, D. G. (2021). When a neonate is born, so is a Microbiota. Life (Basel, Switzerland), 11(2), 148. https://doi.org/10.3390/life11020148
Crudele, L., Gadaleta, R. M., Cariello, M., & Moschetta, A. (2023). Gut microbiota in the pathogenesis and therapeutic approaches of diabetes. EBioMedicine, 97(104821), 104821. https://doi.org/10.1016/j.ebiom.2023.104821
Cryan, J. F., O’Riordan, K. J., Cowan, C. S. M., Sandhu, K. V., Bastiaanssen, T. F. S., Boehme, M., Codagnone, M. G., Cussotto, S., Fulling, C., Golubeva, A. V., Guzzetta, K. E., Jaggar, M., Long-Smith, C. M., Lyte, J. M., Martin, J. A., Molinero-Perez, A., Moloney, G., Morelli, E., Morillas, E., … Dinan, T. G. (2019). The Microbiota-gut-brain axis. Physiological Reviews, 99(4), 1877–2013. https://doi.org/10.1152/physrev.00018.2018
Deng, F., Li, Y., & Zhao, J. (2019). The gut microbiome of healthy long-living people. Aging, 11(2), 289–290. https://doi.org/10.18632/aging.101771
Dinan, T. G., Stanton, C., & Cryan, J. F. (2013). Psychobiotics: A novel class of psychotropic. Biological Psychiatry, 74(10), 720–726. https://doi.org/10.1016/j.biopsych.2013.05.001
Di Vincenzo, F., Del Gaudio, A., Petito, V., Lopetuso, L. R., & Scaldaferri, F. (2024). Gut microbiota, intestinal permeability, and systemic inflammation: a narrative review. Internal and Emergency Medicine, 19(2), 275–293. https://doi.org/10.1007/s11739-023-03374-w
Doenyas, C., Clarke, G., & Cserjési, R. (2025). Gut-brain axis and neuropsychiatric health: recent advances. Scientific Reports, 15(1), 3415. https://doi.org/10.1038/s41598-025-86858-3
Éliás, A. J., Földvári-Nagy, K. C., Al-Gharati, Y. Z., Veres, D. S., Schnabel, T., Teutsch, B., Erőss, B., Hegyi, P., Lenti, K., & Földvári-Nagy, L. (2026). Effect of probiotic supplementation on the gut microbiota diversity in healthy populations: a systematic review and meta-analysis of randomised controlled trials. BMC Medicine, 24(1), 71. https://doi.org/10.1186/s12916-025-04602-0
Fouhy, F., Watkins, C., Hill, C. J., O’Shea, C.-A., Nagle, B., Dempsey, E. M., O’Toole, P. W., Ross, R. P., Ryan, C. A., & Stanton, C. (2019). Perinatal factors affect the gut microbiota up to four years after birth. Nature Communications, 10(1), 1517. https://doi.org/10.1038/s41467-019-09252-4
Gao, M., Wang, J., Liu, P., Tu, H., Zhang, R., Zhang, Y., Sun, N., & Zhang, K. (2023). Gut microbiota composition in depressive disorder: a systematic review, meta-analysis, and meta-regression. Translational Psychiatry, 13(1), 379. https://doi.org/10.1038/s41398-023-02670-5
Gibson, G. R., Hutkins, R., Sanders, M. E., Prescott, S. L., Reimer, R. A., Salminen, S. J., Scott, K., Stanton, C., Swanson, K. S., Cani, P. D., Verbeke, K., & Reid, G. (2017). Expert consensus document: The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics. Nature Reviews. Gastroenterology & Hepatology, 14(8), 491–502. https://doi.org/10.1038/nrgastro.2017.75
González Vázquez, Y., García Cruz, R., Rodríguez-Contreras, V., & Acuña-Gurrola, M. del R. (2026). Efectividad del uso de psicobióticos en las enfermedades mentales: Revisión bibliográfica. Journal of Basic and Applied Psychology Research, 7(14), 14–24. https://doi.org/10.29057/jbapr.v7i14.14442
Hamjane, N., Mechita, M. B., Nourouti, N. G., & Barakat, A. (2024). Gut microbiota dysbiosis -associated obesity and its involvement in cardiovascular diseases and type 2 diabetes. A systematic review. Microvascular Research, 151(104601), 104601. https://doi.org/10.1016/j.mvr.2023.104601
Heidari, M., Maleki Vareki, S., Yaghobi, R., & Karimi, M. H. (2024). Microbiota activation and regulation of adaptive immunity. Frontiers in Immunology, 15, 1429436. https://doi.org/10.3389/fimmu.2024.1429436
Human Microbiome Project Consortium. (2012a). A framework for human microbiome research. Nature, 486(7402), 215–221. https://doi.org/10.1038/nature11209
Human Microbiome Project Consortium. (2012b). Structure, function and diversity of the healthy human microbiome. Nature, 486(7402), 207–214. https://doi.org/10.1038/nature11234
Iqbal, M., Yu, Q., Tang, J., & Xiang, J. (2025). Unraveling the gut microbiota’s role in obesity: key metabolites, microbial species, and therapeutic insights. Journal of Bacteriology, 207(5), e0047924. https://doi.org/10.1128/jb.00479-24
Kasarello, K., Cudnoch-Jedrzejewska, A., & Czarzasta, K. (2023). Communication of gut microbiota and brain via immune and neuroendocrine signaling. Frontiers in Microbiology, 14, 1118529. https://doi.org/10.3389/fmicb.2023.1118529
Li, Y., Li, T., Zhang, Y., Wang, Y., Wu, G., & Tan, Y. (2026). Microbial metabolites in the gut-brain axis: their impact on depression pathophysiology and treatment. Neuroscience, 593, 1–7. https://doi.org/10.1016/j.neuroscience.2025.12.002
Loh, J. S., Mak, W. Q., Tan, L. K. S., Ng, C. X., Chan, H. H., Yeow, S. H., Foo, J. B., Ong, Y. S., How, C. W., & Khaw, K. Y. (2024). Microbiota-gut-brain axis and its therapeutic applications in neurodegenerative diseases. Signal Transduction and Targeted Therapy, 9(1), 37. https://doi.org/10.1038/s41392-024-01743-1
Macura, B., Kiecka, A., & Szczepanik, M. (2024). Intestinal permeability disturbances: causes, diseases and therapy. Clinical and Experimental Medicine, 24(1), 232. https://doi.org/10.1007/s10238-024-01496-9
Man, W. H., de Steenhuijsen Piters, W. A. A., & Bogaert, D. (2017). The microbiota of the respiratory tract: gatekeeper to respiratory health. Nature Reviews. Microbiology, 15(5), 259–270. https://doi.org/10.1038/nrmicro.2017.14
Marchesi, J. R., & Ravel, J. (2015). The vocabulary of microbiome research: a proposal. Microbiome, 3(1), 31. https://doi.org/10.1186/s40168-015-0094-5
Mishra, S., Jain, S., Agadzi, B., & Yadav, H. (2025). A cascade of Microbiota-leaky gut-inflammation- is it a key player in metabolic disorders? Current Obesity Reports, 14(1), 32. https://doi.org/10.1007/s13679-025-00624-0
Missiego-Beltrán, J., & Beltrán-Velasco, A. I. (2024). The role of microbial metabolites in the progression of neurodegenerative diseases-therapeutic approaches: A comprehensive review. International Journal of Molecular Sciences, 25(18), 10041. https://doi.org/10.3390/ijms251810041
Mosquera, F. E. C., Lizcano Martinez, S., & Liscano, Y. (2024). Effectiveness of psychobiotics in the treatment of psychiatric and cognitive disorders: A systematic review of randomized clinical trials. Nutrients, 16(9), 1352. https://doi.org/10.3390/nu16091352
Nakhal, M. M., Yassin, L. K., Alyaqoubi, R., Saeed, S., Alderei, A., Alhammadi, A., Alshehhi, M., Almehairbi, A., Al Houqani, S., BaniYas, S., Qanadilo, H., Ali, B. R., Shehab, S., Statsenko, Y., Meribout, S., Sadek, B., Akour, A., & Hamad, M. I. K. (2024). The Microbiota–gut–brain axis and neurological disorders: A comprehensive review. Life (Basel, Switzerland), 14(10), 1234. https://doi.org/10.3390/life14101234
Ney, L.-M., Wipplinger, M., Grossmann, M., Engert, N., Wegner, V. D., & Mosig, A. S. (2023). Short chain fatty acids: key regulators of the local and systemic immune response in inflammatory diseases and infections. Open Biology, 13(3), 230014. https://doi.org/10.1098/rsob.230014
Niazi, M. K., Hassan, F., Tufail, T., Ismail, M. A., & Riaz, K. (2023). The Role of Microbiome in Psychiatric Diseases (Insomnia and Anxiety/Depression) with Microbiological Mechanisms. Advanced Gut & Microbiome Research, 2023, 1–9. https://doi.org/10.1155/2023/1566684
Nohesara, S., Abdolmaleky, H. M., Thiagalingam, S., & Zhou, J.-R. (2024). Gut microbiota defined epigenomes of Alzheimer’s and Parkinson's diseases reveal novel targets for therapy. Epigenomics, 16(1), 57–77. https://doi.org/10.2217/epi-2023-0342
O’Hara, A. M., & Shanahan, F. (2006). The gut flora as a forgotten organ. EMBO Reports, 7(7), 688–693. https://doi.org/10.1038/sj.embor.7400731
O’Riordan, K. J., Collins, M. K., Moloney, G. M., Knox, E. G., Aburto, M. R., Fülling, C., Morley, S. J., Clarke, G., Schellekens, H., & Cryan, J. F. (2022). Short chain fatty acids: Microbial metabolites for gut-brain axis signalling. Molecular and Cellular Endocrinology, 546(111572), 111572. https://doi.org/10.1016/j.mce.2022.111572
Ortigão, R., Pimentel-Nunes, P., Dinis-Ribeiro, M., & Libânio, D. (2020). Gastrointestinal microbiome - what we need to know in clinical practice. GE Portuguese Journal of Gastroenterology, 27(5), 336–351. https://doi.org/10.1159/000505036
Ovalle, A. (2025). Alterations in vaginal and urinary microbiota in menopause and associated pathologies: A narrative review. Journal of Clinical and Translational Research, 11(5), 29. https://doi.org/10.36922/jctr025150016
Palleja, A., Mikkelsen, K. H., Forslund, S. K., Kashani, A., Allin, K. H., Nielsen, T., Hansen, T. H., Liang, S., Feng, Q., Zhang, C., Pyl, P. T., Coelho, L. P., Yang, H., Wang, J., Typas, A., Nielsen, M. F., Nielsen, H. B., Bork, P., Wang, J., … Pedersen, O. (2018). Recovery of gut microbiota of healthy adults following antibiotic exposure. Nature Microbiology, 3(11), 1255–1265. https://doi.org/10.1038/s41564-018-0257-9
Parker, A., Fonseca, S., & Carding, S. R. (2020). Gut microbes and metabolites as modulators of blood-brain barrier integrity and brain health. Gut Microbes, 11(2), 135–157. https://doi.org/10.1080/19490976.2019.1638722
Qian, X.-B., Chen, T., Xu, Y.-P., Chen, L., Sun, F.-X., Lu, M.-P., & Liu, Y.-X. (2020). A guide to human microbiome research: study design, sample collection, and bioinformatics analysis. Chinese Medical Journal, 133(15), 1844–1855. https://doi.org/10.1097/CM9.0000000000000871
Ramirez, J., Guarner, F., Bustos Fernandez, L., Maruy, A., Sdepanian, V. L., & Cohen, H. (2020). Antibiotics as major disruptors of gut Microbiota. Frontiers in Cellular and Infection Microbiology, 10, 572912. https://doi.org/10.3389/fcimb.2020.572912
Rosenberg, E. (2024). Diversity of bacteria within the human gut and its contribution to the functional unity of holobionts. Npj Biofilms and Microbiomes, 10(1), 134. https://doi.org/10.1038/s41522-024-00580-y
Rusch, J. A., Layden, B. T., & Dugas, L. R. (2023). Signalling cognition: the gut microbiota and hypothalamic-pituitary-adrenal axis. Frontiers in Endocrinology, 14, 1130689. https://doi.org/10.3389/fendo.2023.1130689
Safarchi, A., Al-Qadami, G., Tran, C. D., & Conlon, M. (2025). Understanding dysbiosis and resilience in the human gut microbiome: biomarkers, interventions, and challenges. Frontiers in Microbiology, 16, 1559521. https://doi.org/10.3389/fmicb.2025.1559521
Salinas-Velarde, I. D., Donaciano-Domínguez, J. M., Oros-Pantoja, R., Aguirre-Garrido, J. F., González-Cervantes, R. M., Munguía-Cervantes, J. E., López, M. G., Bustos-Martínez, J., & Soto-Piña, A. E. (2025). Narrative review: Gut Microbiota and its impact on α-syn function in Parkinson’s disease. MicrobiologyOpen, 14(6), e70173. https://doi.org/10.1002/mbo3.70173
Sampson, T. R., Debelius, J. W., Thron, T., Janssen, S., Shastri, G. G., Ilhan, Z. E., Challis, C., Schretter, C. E., Rocha, S., Gradinaru, V., Chesselet, M.-F., Keshavarzian, A., Shannon, K. M., Krajmalnik-Brown, R., Wittung-Stafshede, P., Knight, R., & Mazmanian, S. K. (2016). Gut Microbiota regulate motor deficits and neuroinflammation in a model of Parkinson’s disease. Cell, 167(6), 1469–1480.e12. https://doi.org/10.1016/j.cell.2016.11.018
Sasidharan Pillai, S., Gagnon, C. A., Foster, C., & Ashraf, A. P. (2024). Exploring the gut Microbiota: Key insights into its role in obesity, metabolic syndrome, and type 2 diabetes. The Journal of Clinical Endocrinology and Metabolism, 109(11), 2709–2719. https://doi.org/10.1210/clinem/dgae499
Scheithauer, T. P. M., Rampanelli, E., Nieuwdorp, M., Vallance, B. A., Verchere, C. B., van Raalte, D. H., & Herrema, H. (2020). Gut Microbiota as a trigger for metabolic inflammation in obesity and type 2 diabetes. Frontiers in Immunology, 11, 571731. https://doi.org/10.3389/fimmu.2020.571731
Shao, T., Hsu, R., Rafizadeh, D. L., Wang, L., Bowlus, C. L., Kumar, N., Mishra, J., Timilsina, S., Ridgway, W. M., Gershwin, M. E., Ansari, A. A., Shuai, Z., & Leung, P. S. C. (2023). The gut ecosystem and immune tolerance. Journal of Autoimmunity, 141(103114), 103114. https://doi.org/10.1016/j.jaut.2023.103114
Shibi Anilkumar, A., Thomas, S. M., & Veerabathiran, R. (2025). Gut microbial metabolites as a convergence point between autoimmunity and solid tumors. Gut Microbes Reports, 2(1), 2470805. https://doi.org/10.1080/29933935.2025.2470805
Simpson, R. C., Shanahan, E. R., Scolyer, R. A., & Long, G. V. (2023). Towards modulating the gut microbiota to enhance the efficacy of immune-checkpoint inhibitors. Nature Reviews. Clinical Oncology, 20(10), 697–715. https://doi.org/10.1038/s41571-023-00803-9
Sisubalan, N., Kesika, P., Sivamaruthi, B. S., & Chaiyasut, C. (2026). Psychobiotics in mental health: insights from human clinical trials via the gut-brain axis. Frontiers in Microbiology, 17(1804560), 1804560. https://doi.org/10.3389/fmicb.2026.1804560
Slavin, J. (2013). Fiber and prebiotics: mechanisms and health benefits. Nutrients, 5(4), 1417–1435. https://doi.org/10.3390/nu5041417
Su, Y., & Xia, Y. (2026). Gut microbiota dysbiosis and depression: Bidirectional interactions, mediating pathways, and microecological therapeutics. Current Research in Food Science, 12(101372), 101372. https://doi.org/10.1016/j.crfs.2026.101372
Takahashi, R., Yamakado, H., Uemura, N., Taguchi, T., & Ueda, J. (2025). The gut-brain axis based on α-synuclein propagation-clinical, neuropathological, and experimental evidence. International Journal of Molecular Sciences, 26(9), 3994. https://doi.org/10.3390/ijms26093994
Valles-Colomer, M., Falony, G., Darzi, Y., Tigchelaar, E. F., Wang, J., Tito, R. Y., Schiweck, C., Kurilshikov, A., Joossens, M., Wijmenga, C., Claes, S., Van Oudenhove, L., Zhernakova, A., Vieira-Silva, S., & Raes, J. (2019). The neuroactive potential of the human gut microbiota in quality of life and depression. Nature Microbiology, 4(4), 623–632. https://doi.org/10.1038/s41564-018-0337-x
Wang, L., Zhu, L., & Qin, S. (2019). Gut Microbiota modulation on intestinal mucosal adaptive immunity. Journal of Immunology Research, 2019, 4735040. https://doi.org/10.1155/2019/4735040
Winter, S. E., & Bäumler, A. J. (2023). Gut dysbiosis: Ecological causes and causative effects on human disease. Proceedings of the National Academy of Sciences of the United States of America, 120(50), e2316579120. https://doi.org/10.1073/pnas.2316579120
Wu, Y.-L., Xu, J., Rong, X.-Y., Wang, F., Wang, H.-J., & Zhao, C. (2021). Gut microbiota alterations and health status in aging adults: From correlation to causation. Aging Medicine, 4(3), 206–213. https://doi.org/10.1002/agm2.12167
Xia, H.-H., & Huang, J.-Z. (2025). Tryptophan metabolism at the crossroads of the neuro-immuno-microbial axis: implications for precision medicine in chronic diseases. Frontiers in Cellular and Infection Microbiology, 15(1707850), 1707850. https://doi.org/10.3389/fcimb.2025.1707850
Xiang, J., Tang, J., Kang, F., Ye, J., Cui, Y., Zhang, Z., Wang, J., Wu, S., & Ye, K. (2024). Gut-induced alpha-Synuclein and Tau propagation initiate Parkinson’s and Alzheimer's disease co-pathology and behavior impairments. Neuron, 112(21), 3585–3601.e5. https://doi.org/10.1016/j.neuron.2024.08.003
Xie, Z., Chen, Z., & Ma, G. (2025). Dynamic changes in the pregnancy microbiome and their role in preterm birth. Frontiers in Cellular and Infection Microbiology, 15(1683610), 1683610. https://doi.org/10.3389/fcimb.2025.1683610
Xu, J., & Lu, Y. (2025). The microbiota-gut-brain axis and central nervous system diseases: from mechanisms of pathogenesis to therapeutic strategies. Frontiers in Microbiology, 16, 1583562. https://doi.org/10.3389/fmicb.2025.1583562
Xu, Z., Wang, T., Wang, Y., Li, Y., Sun, Y., & Qiu, H.-J. (2025). Short-chain fatty acids: key antiviral mediators of gut microbiota. Frontiers in Immunology, 16, 1614879. https://doi.org/10.3389/fimmu.2025.1614879
Yi, H., Yong, D., Lee, K., Cho, Y.-J., & Chun, J. (2014). Profiling bacterial community in upper respiratory tracts. BMC Infectious Diseases, 14(1), 583. https://doi.org/10.1186/s12879-014-0583-3
Zerón, A. (2025). Eubiosis y disbiosis.De la simbiosis a la transcriptómica. Revisita ADM, 82(4), 191–196. https://doi.org/10.35366/121010
Zhai, Q., Gao, Y., Wang, M., Li, L., Li, L., Li, J., Ma, Y., Niu, K., & Ye, M. (2025). Characterization of vaginal microbiota across female reproductive phases. Frontiers in Microbiology, 16, 1599965. https://doi.org/10.3389/fmicb.2025.1599965
Zhao, Q., & Elson, C. O. (2018). Adaptive immune education by gut microbiota antigens. Immunology, 154(1), 28–37. https://doi.org/10.1111/imm.12896
Zheng, D., Liwinski, T., & Elinav, E. (2020). Interaction between microbiota and immunity in health and disease. Cell Research, 30(6), 492–506. https://doi.org/10.1038/s41422-020-0332-7
Derechos de autor 2026 Stephany Young Yusty
Esta obra está bajo licencia internacional Creative Commons Reconocimiento 4.0.
.png)
.png)
1.png)
